Novartis PhII Ceritinib (LDK378) in R/R ALK+ Hem Malignancies
Clinical trial NCT02343679 · WITHDRAWN
Trial details
- NCT number
- NCT02343679
- Sponsor
- Anne Beaven, MD
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-05-01
- Primary completion
- 2020-10-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.